Emtricitabine, Rilpivirine, Tenofovir Disoproxil

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

NADAC/unit $114.8597

No Shortage Tier 1: 18.5% 2 Manufacturers 2 ANDAs

Emtricitabine, Rilpivirine, Tenofovir Disoproxil blocks HIV replication by inhibiting reverse transcriptase.

Covered Lives

Generic Manufacturers

GILEAD SCIENCES INCLAURUS LABS LTDMYLAN PHARMACEUTICALS INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Emtricitabine, Rilpivirine, Tenofovir Disoproxil drfinder.aiFind doctors who prescribe Emtricitabine, Rilpivirine, Tenofovir Disoproxil rxnews.aiLatest news about Emtricitabine, Rilpivirine, Tenofovir Disoproxil

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.